The Leukemia Lymphoma Society S Therapy Acceleration

The Leukemia Lymphoma Society S Therapy Acceleration Program vs Craig Miller

The Leukemia Lymphoma Society S Therapy Acceleration Program is a venture capital based in New York, New York, United States. Craig Miller is a private equity based in New York across 709 portfolio companies. Sector focus diverges: The Leukemia Lymphoma Society S Therapy Acceleration Program concentrates on generalist deals and Craig Miller on Proptech.

• Investor type: The Leukemia Lymphoma Society S Therapy Acceleration Program — Venture Capital; Craig Miller — Private Equity
• Headquarters: The Leukemia Lymphoma Society S Therapy Acceleration Program — New York, New York, United States; Craig Miller — New York
• Portfolio companies: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Craig Miller — 709
• Sectors: The Leukemia Lymphoma Society S Therapy Acceleration Program — not disclosed; Craig Miller — Proptech

• The Leukemia & Lymphoma Society’s Therapy Acceleration Program — Venture Capital · New York, New York, United States · The Leukemia Lymphoma Society S Therapy Acceleration Program portfolio
• Craig Miller — Private Equity · New York · 709 tracked deals · Craig Miller portfolio

Similar investors

• Thomas S. Giannetti
• Pal B. Ristvedt
• Strategic Equity Capital NY LLC
• Magnus Grimeland
• Elodie Dupuy
• Victor L. Wu
• Timothy Huang
• Opto Custom GP 2023 LLC
• Antler Special Opportunities GP II LLC
• Steven G. Glenn

Investors like The Leukemia Lymphoma Society S Therapy Acceleration Program · Investors like Craig Miller · The Leukemia Lymphoma Society S Therapy Acceleration Program co-investors · Full investor directory